首页 > 最新文献

Hormone Molecular Biology and Clinical Investigation最新文献

英文 中文
Comparative study of radioprotective effects of endurance training in irradiation-induced nephropathy of rat model. 耐力训练对辐照诱导的大鼠肾病模型的放射保护作用比较研究
IF 1 Q3 Medicine Pub Date : 2024-04-01 eCollection Date: 2024-03-01 DOI: 10.1515/hmbci-2022-0094
Mohammad Parastesh, Shiva Molavi, Samira Moghadasi

Objectives: Considering the antioxidant properties of endurance training, this study aimed to investigate the effects of endurance training on serum levels of oxidative stress and structural changes in the kidney tissue of rats exposed to X-ray irradiation.

Methods: In this experimental study, 24 rats weighing 220±20 g were randomly divided into four groups (healthy control, healthy with moderate-intensity continuous training, X-ray control, and X-ray with moderate-intensity continuous training). The two groups of rats were irradiated with 4 Gy X-rays. The two training groups also performed moderate-intensity continuous training for 10 weeks. Twenty-four hour after the last training session, the blood serum of rats was collected and kidney tissue was isolated for stereological studies.

Results: In this study, X-ray irradiation of the whole body of rats caused a significant increase in kidney volume, cortex volume, interstitial tissue volume, glomerular volume, and serum level of MDA (p≤0.05), but the medulla volume, volume of proximal tubules (total volume, volume of epithelium, and lumen), volume of distal tubules (total volume, volume of epithelium, and lumen), and the length of the proximal and distal tubules had no effect. In addition, TAC and SOD levels were significantly decreased in the radiation control group. Furthermore, performing endurance training in X-ray-irradiated rats significantly reduced kidney volume, cortex volume, glomerular volume, and serum MDA level (p≤0.05).

Conclusions: Moderate-intensity continuous training can improve the rate of destruction of kidney tissue in rats exposed to X-rays by reducing oxidative stress and subsequently increasing antioxidant capacity.

研究目的考虑到耐力训练的抗氧化特性,本研究旨在探讨耐力训练对X射线照射大鼠血清氧化应激水平和肾组织结构变化的影响:方法:本实验将 24 只体重为 220±20 g 的大鼠随机分为四组(健康对照组、接受中等强度持续训练的健康组、X 射线对照组和接受中等强度持续训练的 X 射线组)。两组大鼠均接受 4 Gy X 射线照射。两个训练组还进行了为期 10 周的中等强度持续训练。最后一次训练结束 24 小时后,收集大鼠血清并分离肾脏组织进行立体学研究:结果:对大鼠全身进行 X 射线照射会导致肾脏体积、皮质体积、间质组织体积、肾小球体积和血清 MDA 水平显著增加(p≤0.05),但髓质体积、近端肾小管体积(总体积、上皮细胞体积和管腔)、远端肾小管体积(总体积、上皮细胞体积和管腔)以及近端和远端肾小管长度没有影响。此外,辐射对照组的 TAC 和 SOD 水平明显下降。此外,对X射线照射大鼠进行耐力训练可显著减少肾脏体积、皮质体积、肾小球体积和血清MDA水平(P≤0.05):结论:中等强度的持续训练可以通过减少氧化应激和提高抗氧化能力来改善X射线照射大鼠肾脏组织的破坏速度。
{"title":"Comparative study of radioprotective effects of endurance training in irradiation-induced nephropathy of rat model.","authors":"Mohammad Parastesh, Shiva Molavi, Samira Moghadasi","doi":"10.1515/hmbci-2022-0094","DOIUrl":"10.1515/hmbci-2022-0094","url":null,"abstract":"<p><strong>Objectives: </strong>Considering the antioxidant properties of endurance training, this study aimed to investigate the effects of endurance training on serum levels of oxidative stress and structural changes in the kidney tissue of rats exposed to X-ray irradiation.</p><p><strong>Methods: </strong>In this experimental study, 24 rats weighing 220±20 g were randomly divided into four groups (healthy control, healthy with moderate-intensity continuous training, X-ray control, and X-ray with moderate-intensity continuous training). The two groups of rats were irradiated with 4 Gy X-rays. The two training groups also performed moderate-intensity continuous training for 10 weeks. Twenty-four hour after the last training session, the blood serum of rats was collected and kidney tissue was isolated for stereological studies.</p><p><strong>Results: </strong>In this study, X-ray irradiation of the whole body of rats caused a significant increase in kidney volume, cortex volume, interstitial tissue volume, glomerular volume, and serum level of MDA (p≤0.05), but the medulla volume, volume of proximal tubules (total volume, volume of epithelium, and lumen), volume of distal tubules (total volume, volume of epithelium, and lumen), and the length of the proximal and distal tubules had no effect. In addition, TAC and SOD levels were significantly decreased in the radiation control group. Furthermore, performing endurance training in X-ray-irradiated rats significantly reduced kidney volume, cortex volume, glomerular volume, and serum MDA level (p≤0.05).</p><p><strong>Conclusions: </strong>Moderate-intensity continuous training can improve the rate of destruction of kidney tissue in rats exposed to X-rays by reducing oxidative stress and subsequently increasing antioxidant capacity.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of serum NF-κB levels with peripheral neuropathy in type 2 diabetes mellitus patients: a pilot study. 2 型糖尿病患者血清 NF-κB 水平与周围神经病变的关系:一项试点研究。
IF 1 Q3 Medicine Pub Date : 2024-03-21 eCollection Date: 2024-03-01 DOI: 10.1515/hmbci-2022-0105
Nibedita Priyadarsini, Madumathy Ramachandran, Kishore K Behera, Sheetal Kiran, Sujata Devi

Objectives: Hyperglycaemia-induced inflammation plays a vital role in the development of diabetic peripheral neuropathy (DPN). Recent evidences had reported the involvement of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) in diabetic experimental models. So, this pilot study aimed to evaluate serum NF-κB levels in DPN patients.

Methods: We recruited 50 T2DM patients, of which 25 were T2DM with neuropathy and 25 were T2DM without neuropathy. In all the participants peripheral neuropathy was diagnosed based on Total neuropathy score (TNS). Serum NF-κB levels were measured by ELISA.

Results: We observed that the serum NF-κB levels were higher in DPN patients in comparison to T2DM patients without neuropathy. On spearman correlation, a positive correlation was found between serum NF-κB levels and TNS in the DPN group (r=0.741, p<0.001). The regression model shows the TNS to be an independent determinant of serum NF-κB levels after adjustment for potential confounders like age, duration of diabetes, and HbA1C (B=81.34; p<0.001).

Conclusions: NF-κB activation plays a key role in promoting inflammation which is associated with the progression of DPN. In this respect, the study of NF-κB levels in serum may be an additional diagnostic marker for DPN.

目的:高血糖诱发的炎症在糖尿病周围神经病变(DPN)的发展过程中起着至关重要的作用。最近有证据表明,活化 B 细胞的核因子卡巴轻链增强子(NF-κB)转录因子参与了糖尿病实验模型。因此,本试验性研究旨在评估 DPN 患者的血清 NF-κB 水平:我们招募了 50 名 T2DM 患者,其中 25 名是有神经病变的 T2DM 患者,25 名是没有神经病变的 T2DM 患者。所有参与者的周围神经病变均根据总神经病变评分(TNS)进行诊断。血清 NF-κB 水平通过 ELISA 检测:我们观察到,与没有神经病变的 T2DM 患者相比,DPN 患者的血清 NF-κB 水平更高。在矛曼相关性研究中,我们发现 DPN 组血清 NF-κB 水平与 TNS 呈正相关(r=0.741,p 结论:NF-κB 水平与 TNS 呈正相关:NF-κB活化在促进炎症中起着关键作用,而炎症与DPN的进展有关。因此,研究血清中的 NF-κB 水平可能是诊断 DPN 的另一个指标。
{"title":"Association of serum NF-κB levels with peripheral neuropathy in type 2 diabetes mellitus patients: a pilot study.","authors":"Nibedita Priyadarsini, Madumathy Ramachandran, Kishore K Behera, Sheetal Kiran, Sujata Devi","doi":"10.1515/hmbci-2022-0105","DOIUrl":"10.1515/hmbci-2022-0105","url":null,"abstract":"<p><strong>Objectives: </strong>Hyperglycaemia-induced inflammation plays a vital role in the development of diabetic peripheral neuropathy (DPN). Recent evidences had reported the involvement of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) in diabetic experimental models. So, this pilot study aimed to evaluate serum NF-κB levels in DPN patients.</p><p><strong>Methods: </strong>We recruited 50 T2DM patients, of which 25 were T2DM with neuropathy and 25 were T2DM without neuropathy. In all the participants peripheral neuropathy was diagnosed based on Total neuropathy score (TNS). Serum NF-κB levels were measured by ELISA.</p><p><strong>Results: </strong>We observed that the serum NF-κB levels were higher in DPN patients in comparison to T2DM patients without neuropathy. On spearman correlation, a positive correlation was found between serum NF-κB levels and TNS in the DPN group (r=0.741, p<0.001). The regression model shows the TNS to be an independent determinant of serum NF-κB levels after adjustment for potential confounders like age, duration of diabetes, and HbA1C (B=81.34; p<0.001).</p><p><strong>Conclusions: </strong>NF-κB activation plays a key role in promoting inflammation which is associated with the progression of DPN. In this respect, the study of NF-κB levels in serum may be an additional diagnostic marker for DPN.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development. 微小核糖核酸、氧化应激和基因毒性是癌症发展病理生物学的主要诱因。
IF 1.1 Q3 Medicine Pub Date : 2024-03-21 eCollection Date: 2024-06-01 DOI: 10.1515/hmbci-2023-0012
Sogand Vahidi, Shahram Agah, Ebrahim Mirzajani, Elahe Asghari Gharakhyli, Seyedeh Elham Norollahi, Morteza Rahbar Taramsari, Kosar Babaei, Ali Akbar Samadani

Cancer is one of the most serious leading causes of death in the world. Many eclectic factors are involved in cancer progression including genetic and epigenetic alongside environmental ones. In this account, the performance and fluctuations of microRNAs are significant in cancer diagnosis and treatment, particularly as diagnostic biomarkers in oncology. So, microRNAs manage and control the gene expression after transcription by mRNA degradation, or also they can inhibit their translation. Conspicuously, these molecular structures take part in controlling the cellular, physiological and pathological functions, which many of them can accomplish as tumor inhibitors or oncogenes. Relatively, Oxidative stress is defined as the inequality between the creation of reactive oxygen species (ROS) and the body's ability to detoxify the reactive mediators or repair the resulting injury. ROS and microRNAs have been recognized as main cancer promoters and possible treatment targets. Importantly, genotoxicity has been established as the primary reason for many diseases as well as several malignancies. The procedures have no obvious link with mutagenicity and influence the organization, accuracy of the information, or fragmentation of DNA. Conclusively, mutations in these patterns can lead to carcinogenesis. In this review article, we report the impressive and practical roles of microRNAs, oxidative stress, and genotoxicity in the pathobiology of cancer development in conjunction with their importance as reliable cancer biomarkers and their association with circulating miRNA, exosomes and exosomal miRNAs, RNA remodeling, DNA methylation, and other molecular elements in oncology.

癌症是世界上最严重的致死原因之一。癌症的发展涉及多种因素,包括遗传因素、表观遗传因素和环境因素。因此,microRNAs 的表现和波动在癌症诊断和治疗中具有重要意义,尤其是作为肿瘤学的诊断生物标志物。因此,microRNA 通过降解 mRNA 来管理和控制转录后的基因表达,或者抑制基因的翻译。显而易见,这些分子结构参与控制细胞、生理和病理功能,其中许多可作为肿瘤抑制剂或致癌基因发挥作用。相对而言,氧化应激被定义为活性氧(ROS)的产生与机体解毒活性介质或修复由此造成的损伤的能力之间的不平等。ROS 和 microRNA 被认为是癌症的主要诱因和可能的治疗目标。重要的是,基因毒性已被确定为许多疾病和几种恶性肿瘤的主要原因。这些程序与突变性没有明显联系,但会影响 DNA 的组织、信息的准确性或破碎。可以肯定的是,这些模式的突变会导致致癌。在这篇综述文章中,我们报告了微RNA、氧化应激和基因毒性在癌症发展的病理生物学中令人印象深刻的实际作用,以及它们作为可靠的癌症生物标志物的重要性及其与循环miRNA、外泌体和外泌体miRNA、RNA重塑、DNA甲基化和肿瘤学中其他分子元素的关联。
{"title":"microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development.","authors":"Sogand Vahidi, Shahram Agah, Ebrahim Mirzajani, Elahe Asghari Gharakhyli, Seyedeh Elham Norollahi, Morteza Rahbar Taramsari, Kosar Babaei, Ali Akbar Samadani","doi":"10.1515/hmbci-2023-0012","DOIUrl":"10.1515/hmbci-2023-0012","url":null,"abstract":"<p><p>Cancer is one of the most serious leading causes of death in the world. Many eclectic factors are involved in cancer progression including genetic and epigenetic alongside environmental ones. In this account, the performance and fluctuations of microRNAs are significant in cancer diagnosis and treatment, particularly as diagnostic biomarkers in oncology. So, microRNAs manage and control the gene expression after transcription by mRNA degradation, or also they can inhibit their translation. Conspicuously, these molecular structures take part in controlling the cellular, physiological and pathological functions, which many of them can accomplish as tumor inhibitors or oncogenes. Relatively, Oxidative stress is defined as the inequality between the creation of reactive oxygen species (ROS) and the body's ability to detoxify the reactive mediators or repair the resulting injury. ROS and microRNAs have been recognized as main cancer promoters and possible treatment targets. Importantly, genotoxicity has been established as the primary reason for many diseases as well as several malignancies. The procedures have no obvious link with mutagenicity and influence the organization, accuracy of the information, or fragmentation of DNA. Conclusively, mutations in these patterns can lead to carcinogenesis. In this review article, we report the impressive and practical roles of microRNAs, oxidative stress, and genotoxicity in the pathobiology of cancer development in conjunction with their importance as reliable cancer biomarkers and their association with circulating miRNA, exosomes and exosomal miRNAs, RNA remodeling, DNA methylation, and other molecular elements in oncology.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The nongenomic neuroprotective effects of estrogen, E2-BSA, and G1 following traumatic brain injury: PI3K/Akt and histopathological study. 脑外伤后雌激素、E2-BSA 和 G1 的非基因组神经保护作用:PI3K/Akt和组织病理学研究。
IF 1 Q3 Medicine Pub Date : 2024-03-20 eCollection Date: 2024-03-01 DOI: 10.1515/hmbci-2023-0066
Ladan Amirkhosravi, Mohammad Khaksari, Mojgan Sanjari, Parisa Khorasani

Objectives: Studies suggest that both genomic and nongenomic pathways are involved in mediating the salutary effects of steroids following traumatic brain injury (TBI). This study investigated the nongenomic effects of 17β-estradiol (E2) mediated by the PI3K/p-Akt pathway after TBI.

Methods: Ovariectomized rats were apportioned to E2, E2-BSA (E2 conjugated to bovine serum albumin), G1 [G-protein-coupled estrogen receptor agonist (GPER)] or their vehicle was injected following TBI, whereas ICI (classical estrogen receptor antagonist), G15 (GPER antagonist), ICI + G15, and their vehicles were injected before the induction of TBI and injection of drugs. Diffuse TBI was induced by the Marmarou model. Evans blue (EBC, 5 h), brain water contents (BWC), histopathological changes, and brain PI3K and p-Akt protein expressions were measured 24 h after TBI. The veterinary comma scale (VCS) was assessed before and at different times after TBI.

Results: The results showed a reduction in BWC and EBC and increased VCS in the E2, E2-BSA, and G1 groups. Also, E2, E2-BSA, and G1 reduced brain edema, inflammation, and apoptosis. The ICI and G15 inhibited the beneficial effects of E2, E2-BSA, and G1 on these parameters. All drugs, following TBI, prevented the reduction of brain PI3K/p-Akt expression. The individual or combined use of ICI and G15 eliminated the beneficial effects of E2, E2-BSA, and G1 on PI3K/p-Akt expressions.

Conclusions: These findings indicated that PI3K/p-Akt pathway plays a critical role in mediating the salutary effects of estradiol on histopathological changes and neurological outcomes following TBI, suggesting that GPER and classic ERs are involved in regulating the expression of PI3K/p-Akt.

目的:研究表明,在创伤性脑损伤(TBI)后,基因组和非基因组途径都参与介导类固醇的有益作用。本研究调查了创伤性脑损伤后 PI3K/p-Akt 通路介导的 17β-estradiol (E2) 的非基因组效应:方法:将切除卵巢的大鼠按比例分为E2、E2-BSA(E2与牛血清白蛋白共轭)、G1[G蛋白偶联雌激素受体激动剂(GPER)]或它们的载体,在诱导TBI和注射药物前注射ICI(经典雌激素受体拮抗剂)、G15(GPER拮抗剂)、ICI + G15和它们的载体。弥漫性 TBI 由 Marmarou 模型诱导。创伤性脑损伤24小时后测量埃文斯蓝(EBC,5小时)、脑含水量(BWC)、组织病理学变化以及脑PI3K和p-Akt蛋白表达。对创伤性脑损伤前和创伤性脑损伤后不同时间的兽医逗号量表(VCS)进行了评估:结果:结果显示,E2、E2-BSA 和 G1 组的 BWC 和 EBC 减少,VCS 增加。此外,E2、E2-BSA 和 G1 还能减轻脑水肿、炎症和细胞凋亡。ICI 和 G15 可抑制 E2、E2-BSA 和 G1 对这些参数的有益影响。所有药物在创伤性脑损伤后都能阻止脑 PI3K/p-Akt 表达的减少。单独或联合使用 ICI 和 G15 可消除 E2、E2-BSA 和 G1 对 PI3K/p-Akt 表达的有利影响:这些研究结果表明,PI3K/p-Akt通路在介导雌二醇对创伤性脑损伤后组织病理学变化和神经系统预后的有益影响中起着关键作用,这表明GPER和经典的ERs参与了PI3K/p-Akt表达的调控。
{"title":"The nongenomic neuroprotective effects of estrogen, E2-BSA, and G1 following traumatic brain injury: PI3K/Akt and histopathological study.","authors":"Ladan Amirkhosravi, Mohammad Khaksari, Mojgan Sanjari, Parisa Khorasani","doi":"10.1515/hmbci-2023-0066","DOIUrl":"10.1515/hmbci-2023-0066","url":null,"abstract":"<p><strong>Objectives: </strong>Studies suggest that both genomic and nongenomic pathways are involved in mediating the salutary effects of steroids following traumatic brain injury (TBI). This study investigated the nongenomic effects of 17β-estradiol (E2) mediated by the PI3K/p-Akt pathway after TBI.</p><p><strong>Methods: </strong>Ovariectomized rats were apportioned to E2, E2-BSA (E2 conjugated to bovine serum albumin), G1 [G-protein-coupled estrogen receptor agonist (GPER)] or their vehicle was injected following TBI, whereas ICI (classical estrogen receptor antagonist), G15 (GPER antagonist), ICI + G15, and their vehicles were injected before the induction of TBI and injection of drugs. Diffuse TBI was induced by the Marmarou model. Evans blue (EBC, 5 h), brain water contents (BWC), histopathological changes, and brain PI3K and p-Akt protein expressions were measured 24 h after TBI. The veterinary comma scale (VCS) was assessed before and at different times after TBI.</p><p><strong>Results: </strong>The results showed a reduction in BWC and EBC and increased VCS in the E2, E2-BSA, and G1 groups. Also, E2, E2-BSA, and G1 reduced brain edema, inflammation, and apoptosis. The ICI and G15 inhibited the beneficial effects of E2, E2-BSA, and G1 on these parameters. All drugs, following TBI, prevented the reduction of brain PI3K/p-Akt expression. The individual or combined use of ICI and G15 eliminated the beneficial effects of E2, E2-BSA, and G1 on PI3K/p-Akt expressions.</p><p><strong>Conclusions: </strong>These findings indicated that PI3K/p-Akt pathway plays a critical role in mediating the salutary effects of estradiol on histopathological changes and neurological outcomes following TBI, suggesting that GPER and classic ERs are involved in regulating the expression of PI3K/p-Akt.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mature cystic ovarian teratoma with squamous cell carcinoma transformation: a case report and literature review. 成熟囊性卵巢畸胎瘤伴鳞状细胞癌转化:病例报告和文献综述。
IF 1 Q3 Medicine Pub Date : 2024-01-30 eCollection Date: 2024-03-01 DOI: 10.1515/hmbci-2023-0001
Mahdi Abdoli Shadbad, Roghaiyeh Derogar, Ali Akbar Shekarchi, Farideh Akbari, Mehri Jafari Shobeiri

Objectives: Cancerous transformation in mature cystic ovarian teratoma is rare. Herein, we reported a case of squamous cell carcinoma transformation in mature cystic ovarian teratoma and performed an in-depth literature review to highlight the risk factors, prognosis, and suggested treatment for these patients.

Case presentation: We report a 66-years old postmenopausal woman diagnosed with a 120×90 (mm) mass at the left adnexa compatible with mature cystic ovarian teratoma. Following resection, the histopathological investigations showed malignant transformation in her mature cystic ovarian teratoma, and the immunohistochemistry for cytokeratin (CK) 5/6 and tumor protein 63 (P63) indicated squamous cell carcinoma transformation. She has been observed for her stage IA tumor and has been cancer-free for 6 months.

Conclusions: Although malignant transformation in mature cystic ovarian teratoma is rare, it should be suspected if certain risk factors, e.g., elderly and high tumor size, exist. Stage IA patients' prognosis is favorable, and chemotherapy is not recommended.

目的:成熟囊性卵巢畸胎瘤癌变非常罕见。在此,我们报告了一例成熟囊性卵巢畸胎瘤鳞状细胞癌转化病例,并进行了深入的文献综述,以强调此类患者的风险因素、预后和治疗建议:我们报告了一名66岁绝经后妇女的病例,她被诊断为左侧附件120×90(mm)肿块,符合成熟囊性卵巢畸胎瘤。切除术后,组织病理学检查显示她的成熟囊性卵巢畸胎瘤发生了恶性转化,细胞角蛋白(CK)5/6 和肿瘤蛋白 63(P63)的免疫组化显示为鳞状细胞癌转化。结论:虽然成熟性卵巢囊性畸胎瘤的恶性转化率较低,但其恶性程度却很高:结论:虽然成熟囊性卵巢畸胎瘤的恶性转化非常罕见,但如果存在某些危险因素,如老年人和肿瘤体积较大,则应怀疑其恶性转化。IA期患者预后良好,不建议化疗。
{"title":"Mature cystic ovarian teratoma with squamous cell carcinoma transformation: a case report and literature review.","authors":"Mahdi Abdoli Shadbad, Roghaiyeh Derogar, Ali Akbar Shekarchi, Farideh Akbari, Mehri Jafari Shobeiri","doi":"10.1515/hmbci-2023-0001","DOIUrl":"10.1515/hmbci-2023-0001","url":null,"abstract":"<p><strong>Objectives: </strong>Cancerous transformation in mature cystic ovarian teratoma is rare. Herein, we reported a case of squamous cell carcinoma transformation in mature cystic ovarian teratoma and performed an in-depth literature review to highlight the risk factors, prognosis, and suggested treatment for these patients.</p><p><strong>Case presentation: </strong>We report a 66-years old postmenopausal woman diagnosed with a 120×90 (mm) mass at the left adnexa compatible with mature cystic ovarian teratoma. Following resection, the histopathological investigations showed malignant transformation in her mature cystic ovarian teratoma, and the immunohistochemistry for cytokeratin (CK) 5/6 and tumor protein 63 (P63) indicated squamous cell carcinoma transformation. She has been observed for her stage IA tumor and has been cancer-free for 6 months.</p><p><strong>Conclusions: </strong>Although malignant transformation in mature cystic ovarian teratoma is rare, it should be suspected if certain risk factors, e.g., elderly and high tumor size, exist. Stage IA patients' prognosis is favorable, and chemotherapy is not recommended.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological activities of African medicinal plants in the treatment of erectile dysfunction: a mechanistic perspective. 非洲药用植物在治疗勃起功能障碍方面的生物活性:机理视角。
IF 1 Q3 Medicine Pub Date : 2024-01-16 eCollection Date: 2023-12-01 DOI: 10.1515/hmbci-2022-0090
Olorunfemi Oyewole Babalola, Opeyemi Iwaloye, Paul Olamide Ottu, Precious Olayinka Aturamu, Femi Olawale

The global incidence of erectile dysfunction is increasingly becoming a significant health concern, as its frequency demonstrates a consistent upward trajectory each year. In recent years, FDA-approved drugs like sildenafil among others has been approved to treat this disorder however the drug is not without its own side effects. In a bid to develop alternative therapeutic option, scientists have now turned to traditional medicine in search of a treatment regimen. Africa is blessed with numerous medicinal plants used in the treatment and management of several diseases including erectile dysfunction. Due to limited access to modern medicine and high-quality medical facilities, a significant number of individuals in Africa continue to depend on traditional medicine as a means of addressing critical health issues. Perhaps one of the grossly explored medicinal properties of plants in Africa is for erectile function. Through years of extensive research in medicinal plants, several plants indigenous to Africa have been identified to show profound ability to mitigate erectile dysfunction. While previous reports have indeed corroborated the ability of this plant to abate erectile dysfunction, there is still a dearth of information regarding the mechanistic aspect of these plants. Hence, the current review aims to provide a comprehensive mechanistic perspective to the major African medicinal plant which have been reported to be effective in the treatment of erectile dysfunction.

由于勃起功能障碍的发病率呈逐年上升趋势,全球勃起功能障碍的发病率正日益成为一个重要的健康问题。近年来,美国食品和药物管理局已批准西地那非等药物用于治疗这种疾病,但这种药物并非没有副作用。为了开发替代疗法,科学家们转而从传统医学中寻找治疗方案。非洲有许多药用植物,可用于治疗和控制包括勃起功能障碍在内的多种疾病。由于难以获得现代医学和高质量的医疗设施,非洲相当多的人继续依赖传统医学来解决关键的健康问题。在非洲,勃起功能可能是被广泛开发的植物药用特性之一。通过多年来对药用植物的广泛研究,已发现几种非洲本土植物具有缓解勃起功能障碍的强大功效。虽然之前的报告确实证实了这种植物能够缓解勃起功能障碍,但有关这些植物的机理方面的信息仍然匮乏。因此,本综述旨在从机理角度全面介绍据报道可有效治疗勃起功能障碍的主要非洲药用植物。
{"title":"Biological activities of African medicinal plants in the treatment of erectile dysfunction: a mechanistic perspective.","authors":"Olorunfemi Oyewole Babalola, Opeyemi Iwaloye, Paul Olamide Ottu, Precious Olayinka Aturamu, Femi Olawale","doi":"10.1515/hmbci-2022-0090","DOIUrl":"10.1515/hmbci-2022-0090","url":null,"abstract":"<p><p>The global incidence of erectile dysfunction is increasingly becoming a significant health concern, as its frequency demonstrates a consistent upward trajectory each year. In recent years, FDA-approved drugs like sildenafil among others has been approved to treat this disorder however the drug is not without its own side effects. In a bid to develop alternative therapeutic option, scientists have now turned to traditional medicine in search of a treatment regimen. Africa is blessed with numerous medicinal plants used in the treatment and management of several diseases including erectile dysfunction. Due to limited access to modern medicine and high-quality medical facilities, a significant number of individuals in Africa continue to depend on traditional medicine as a means of addressing critical health issues. Perhaps one of the grossly explored medicinal properties of plants in Africa is for erectile function. Through years of extensive research in medicinal plants, several plants indigenous to Africa have been identified to show profound ability to mitigate erectile dysfunction. While previous reports have indeed corroborated the ability of this plant to abate erectile dysfunction, there is still a dearth of information regarding the mechanistic aspect of these plants. Hence, the current review aims to provide a comprehensive mechanistic perspective to the major African medicinal plant which have been reported to be effective in the treatment of erectile dysfunction.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139466604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study. 吡格列酮和利拉利汀对二甲双胍治疗的 2 型糖尿病患者血糖控制、血脂状况和 hs-CRP 的影响:一项比较研究。
IF 1 Q3 Medicine Pub Date : 2023-12-26 eCollection Date: 2023-12-01 DOI: 10.1515/hmbci-2022-0070
Batool Zamani, Seyyed Mashaalah Tabatabizadeh, Hamidreza Gilasi, Shadi Yazdani

Objectives: The purpose of this study was to compare the effects of pioglitazone and linagliptin on glycemic control, lipid profile and high-sensitivity C-reactive protein (hs-CRP) parameters in patients with type 2 diabetes treated with metformin.

Methods: The present randomized clinical trial was conducted on 60 patients with type 2 diabetes treated with metformin in the age range of 30-60 years. The participants with informed consent were randomly assigned to receive pioglitazone or linagliptin. The first intervention group (n=30) received 30 mg of pioglitazone daily and the second intervention group (n=30) received 5 mg of linagliptin daily for 12 weeks. Fasting blood samples were taken from patients at the baseline and after 12 weeks to measure related variables. The current study was approved in Kashan University of Medical Sciences (with the code of ethics of IR.KAUMS.MEDNT.REC.1398.016), and the Iranian Registry of Clinical Trials (with the registration number of IRCT20170513033941N66).

Results: The linagliptin administration significantly reduced serum levels of fasting blood sugar (p=0.03), blood sugar 2 h after a meal (p=0.02), glycosylated hemoglobin (p=0.02) and hs-CRP (p=0.005) after 12 weeks compared with pioglitazone. In contrast, the pioglitazone administration significantly decreased triglyceride levels (p=0.01) and increased HDL-cholesterol (p=0.002) compared to linagliptin. In addition, the administration of both linagliptin and pioglitazone drugs had no significant effect on LDL-cholesterol, total cholesterol, systolic and diastolic blood pressure, creatinine and blood urea.

Conclusions: The present study demonstrated the superiority of linagliptin over pioglitazone for glycemic control, although pioglitazone compared to linagliptin showed greater efficacy in reducing triglycerides and raising HDL-cholesterol.

研究目的本研究旨在比较吡格列酮和利拉利汀对二甲双胍治疗的2型糖尿病患者血糖控制、血脂状况和高敏C反应蛋白(hs-CRP)参数的影响:本随机临床试验的对象是 60 名接受二甲双胍治疗的 2 型糖尿病患者,年龄在 30-60 岁之间。获得知情同意的参与者被随机分配接受吡格列酮或利拉利汀治疗。第一干预组(30 人)每天服用 30 毫克吡格列酮,第二干预组(30 人)每天服用 5 毫克利拉利汀,为期 12 周。在基线和 12 周后分别采集患者的空腹血样,以测量相关变量。本研究获得了卡尚医科大学(伦理守则为 IR.KAUMS.MEDNT.REC.1398.016)和伊朗临床试验登记处(登记号为 IRCT20170513033941N66)的批准:结果:与吡格列酮相比,12周后服用利拉利汀可显著降低血清中的空腹血糖水平(p=0.03)、餐后2小时血糖水平(p=0.02)、糖化血红蛋白水平(p=0.02)和hs-CRP水平(p=0.005)。相反,与利拉利汀相比,服用吡格列酮可显著降低甘油三酯水平(p=0.01),提高高密度脂蛋白胆固醇(p=0.002)。此外,服用利拉利汀和吡格列酮对低密度脂蛋白胆固醇、总胆固醇、收缩压和舒张压、肌酐和血尿素均无明显影响:本研究表明,在控制血糖方面,利拉利汀优于吡格列酮,但与利拉利汀相比,吡格列酮在降低甘油三酯和提高高密度脂蛋白胆固醇方面的疗效更好。
{"title":"Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study.","authors":"Batool Zamani, Seyyed Mashaalah Tabatabizadeh, Hamidreza Gilasi, Shadi Yazdani","doi":"10.1515/hmbci-2022-0070","DOIUrl":"10.1515/hmbci-2022-0070","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to compare the effects of pioglitazone and linagliptin on glycemic control, lipid profile and high-sensitivity C-reactive protein (hs-CRP) parameters in patients with type 2 diabetes treated with metformin.</p><p><strong>Methods: </strong>The present randomized clinical trial was conducted on 60 patients with type 2 diabetes treated with metformin in the age range of 30-60 years. The participants with informed consent were randomly assigned to receive pioglitazone or linagliptin. The first intervention group (n=30) received 30 mg of pioglitazone daily and the second intervention group (n=30) received 5 mg of linagliptin daily for 12 weeks. Fasting blood samples were taken from patients at the baseline and after 12 weeks to measure related variables. The current study was approved in Kashan University of Medical Sciences (with the code of ethics of IR.KAUMS.MEDNT.REC.1398.016), and the Iranian Registry of Clinical Trials (with the registration number of IRCT20170513033941N66).</p><p><strong>Results: </strong>The linagliptin administration significantly reduced serum levels of fasting blood sugar (p=0.03), blood sugar 2 h after a meal (p=0.02), glycosylated hemoglobin (p=0.02) and hs-CRP (p=0.005) after 12 weeks compared with pioglitazone. In contrast, the pioglitazone administration significantly decreased triglyceride levels (p=0.01) and increased HDL-cholesterol (p=0.002) compared to linagliptin. In addition, the administration of both linagliptin and pioglitazone drugs had no significant effect on LDL-cholesterol, total cholesterol, systolic and diastolic blood pressure, creatinine and blood urea.</p><p><strong>Conclusions: </strong>The present study demonstrated the superiority of linagliptin over pioglitazone for glycemic control, although pioglitazone compared to linagliptin showed greater efficacy in reducing triglycerides and raising HDL-cholesterol.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does leptin cause proximal gastric cancer in the obese? The role of serum leptin in the etiology of proximal gastric cancer. 瘦素会导致肥胖者患近端胃癌吗?血清瘦素在近端胃癌病因学中的作用。
IF 1 Q3 Medicine Pub Date : 2023-12-25 eCollection Date: 2023-12-01 DOI: 10.1515/hmbci-2022-0101
Tomaz Jagric, Gaja Hladnik, Rok Kolaric, Marjeta Dugonik, Evgenija Homsak

Objectives: The aim of the present study was to determine the correlation between obesity, serum levels of leptin and proximal gastric cancer.

Methods: Sixty-four gastric cancer patients operated on with curative intent were included in the study. We determined the correlation between the preoperative serum levels of leptin and the tumor's location.

Results: Serum leptin levels were correlated significantly with the proximal third location (p=0.04), gastric outlet obstructing tumors (p<0.0001), CRP levels (p=0.03) and BMI (p<0.0001). Patients with high serum levels of leptin had significantly more intestinal types of gastric cancer (p=0.033) and better differentiation (p=0.009). The linear regression model determined the proximal tumor location (beta: 0.467; p=0.045), BMI (beta: 0.657; p=0.001), high preoperative serum albumin (beta: 0.563; p=0.016) and the presence of pyloric stenosis (beta: 0.525; p=0.006) as related significantly to serum leptin levels. The Cox proportional hazard model identified age (HR: 0.003; 95 % CI: 0-0.794; p=0.041), preoperative serum levels of leptin (HR: 0.125; 95 % CI: 0.018-0.887; p=0.037) and the number of extracted LNs (HR: 0.001; 95 % CI: 0-0.677; p=0.038) as independent prognostic factors.

Conclusions: Serum levels of leptin were significantly elevated in patients with proximal gastric cancer, suggesting that the leptin's effect might be due to its systemic secretion. This might explain the higher incidence of proximal gastric cancer in obese patients. Elevated serum leptin levels were an independent prognostic factor.

目的:本研究旨在确定肥胖、血清瘦素水平与近端胃癌之间的相关性:本研究旨在确定肥胖、血清瘦素水平与近端胃癌之间的相关性:研究纳入了 64 名接受根治性手术的胃癌患者。我们测定了术前血清瘦素水平与肿瘤位置之间的相关性:结果:血清瘦素水平与肿瘤近端第三位置(P=0.04)、胃出口梗阻性肿瘤(P结论:血清瘦素水平与肿瘤近端第三位置(P=0.04)、胃出口梗阻性肿瘤(P=0.04)显著相关:近端胃癌患者的血清瘦素水平明显升高,表明瘦素的作用可能是由于其全身性分泌。这可能是肥胖患者近端胃癌发病率较高的原因。血清瘦素水平升高是一个独立的预后因素。
{"title":"Does leptin cause proximal gastric cancer in the obese? The role of serum leptin in the etiology of proximal gastric cancer.","authors":"Tomaz Jagric, Gaja Hladnik, Rok Kolaric, Marjeta Dugonik, Evgenija Homsak","doi":"10.1515/hmbci-2022-0101","DOIUrl":"10.1515/hmbci-2022-0101","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the present study was to determine the correlation between obesity, serum levels of leptin and proximal gastric cancer.</p><p><strong>Methods: </strong>Sixty-four gastric cancer patients operated on with curative intent were included in the study. We determined the correlation between the preoperative serum levels of leptin and the tumor's location.</p><p><strong>Results: </strong>Serum leptin levels were correlated significantly with the proximal third location (p=0.04), gastric outlet obstructing tumors (p<0.0001), CRP levels (p=0.03) and BMI (p<0.0001). Patients with high serum levels of leptin had significantly more intestinal types of gastric cancer (p=0.033) and better differentiation (p=0.009). The linear regression model determined the proximal tumor location (beta: 0.467; p=0.045), BMI (beta: 0.657; p=0.001), high preoperative serum albumin (beta: 0.563; p=0.016) and the presence of pyloric stenosis (beta: 0.525; p=0.006) as related significantly to serum leptin levels. The Cox proportional hazard model identified age (HR: 0.003; 95 % CI: 0-0.794; p=0.041), preoperative serum levels of leptin (HR: 0.125; 95 % CI: 0.018-0.887; p=0.037) and the number of extracted LNs (HR: 0.001; 95 % CI: 0-0.677; p=0.038) as independent prognostic factors.</p><p><strong>Conclusions: </strong>Serum levels of leptin were significantly elevated in patients with proximal gastric cancer, suggesting that the leptin's effect might be due to its systemic secretion. This might explain the higher incidence of proximal gastric cancer in obese patients. Elevated serum leptin levels were an independent prognostic factor.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138884885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydroalcoholic extract of Scrophularia striata has a significant therapeutic effect on thioacetamide-induced liver cirrhosis in rats. 条叶莨菪的水醇提取物对硫代乙酰胺诱导的大鼠肝硬化有显著的治疗作用。
IF 1 Q3 Medicine Pub Date : 2023-12-22 eCollection Date: 2023-12-01 DOI: 10.1515/hmbci-2022-0106
Jamal Amri, Mohammad Jamalian, Zahre Salami, Ahmad Akbari, Mona Alaee, Fatemeh Azizi Soleiman, Abbas Alimoradian

Objectives: Liver cirrhosis is one of the most important causes of death from liver diseases. Nowadays, the use of herbal medicines has increased due to its availability, less side effects and cheapness for the treatment of liver diseases. The present study was conducted to examine therapeutic effects of hydroalcoholic extract of Scrophularia striata (S. striata) on thioacetamide-induced liver cirrhosis in rats through evaluate its effects on oxidative stress markers and the expression of metalloproteinase 1 (TIMP 1), toll-like receptor-4 (TLR-4), and Mitofusin (MFN2) genes.

Methods: 24 male rats were selected by simple random sampling. Rats were randomly assigned to four groups: group I: healthy rats, group II: thioacetamide (TAA) injected rats, group III: TAA injected rats+100 mg/kg bw of S. striata and group IV: TAA injected rats+200 mg/kg bw of S. striata. Liver cirrhosis was induced in rats by a 300 mg/kg bw TAA administration twice with an interval of 24 h. After 8 weeks of treatment by S. striata at doses of 100 and 200 mg/kg bw, biochemical factors and oxidative stress markers (SOD, TAC, GPX, CAT and MDA) were measured using spectrophotometric methods. Also, gene expression of TIMP 1, TLR-4, and MFN2 were analyzed using real-time PCR. ANOVA and Bonferroni post hoc test analysis were applied to evaluate the data.

Results: The results showed the S. striata extract significantly improve the serum ALT, AST and ALP levels, TIMP 1, TLR-4, and MFN2 genes and oxidative stress markers (SOD, TAC, GPX, CAT and MDA) in the liver tissues when compared to control group (p<0.05). Also, it was found that the beneficial effects of the S. striata were dose-dependent.

Conclusions: Based on the results obtained S. striata by reducing the expression of TIMP 1, TLR-4, and MFN2 genes and improving oxidative stress might be used as adjuvant treatment for liver cirrhosis.

目的:肝硬化是肝病致死的最主要原因之一。如今,草药因其易得、副作用小、价格便宜等特点,在肝病治疗中的使用越来越多。本研究通过评估黄芩水醇提取物对氧化应激标志物以及金属蛋白酶 1 (TIMP 1)、toll 样受体-4 (TLR-4) 和 Mitofusin (MFN2) 基因表达的影响,研究其对硫代乙酰胺诱导的大鼠肝硬化的治疗效果。大鼠随机分为四组:Ⅰ组:健康大鼠;Ⅱ组:注射硫代乙酰胺(TAA)大鼠;Ⅲ组:注射TAA+100 mg/kg体重的条纹叶藻大鼠;Ⅳ组:注射TAA+200 mg/kg体重的条纹叶藻大鼠。给大鼠注射两次 300 毫克/千克体重的 TAA,每次间隔 24 小时,诱发肝硬化。以 100 和 200 毫克/千克体重的剂量给大鼠注射横纹肌苷 8 周后,采用分光光度法测量生化因子和氧化应激标记物(SOD、TAC、GPX、CAT 和 MDA)。此外,还使用实时 PCR 分析了 TIMP 1、TLR-4 和 MFN2 的基因表达。对数据进行方差分析和 Bonferroni 后验分析:结果表明,与对照组相比,S. striata 提取物能明显改善血清 ALT、AST 和 ALP 水平、TIMP 1、TLR-4 和 MFN2 基因以及肝组织中的氧化应激标记物(SOD、TAC、GPX、CAT 和 MDA):根据研究结果,S. striata 能降低 TIMP 1、TLR-4 和 MFN2 基因的表达,改善氧化应激,可作为肝硬化的辅助治疗药物。
{"title":"Hydroalcoholic extract of <i>Scrophularia striata</i> has a significant therapeutic effect on thioacetamide-induced liver cirrhosis in rats.","authors":"Jamal Amri, Mohammad Jamalian, Zahre Salami, Ahmad Akbari, Mona Alaee, Fatemeh Azizi Soleiman, Abbas Alimoradian","doi":"10.1515/hmbci-2022-0106","DOIUrl":"10.1515/hmbci-2022-0106","url":null,"abstract":"<p><strong>Objectives: </strong>Liver cirrhosis is one of the most important causes of death from liver diseases. Nowadays, the use of herbal medicines has increased due to its availability, less side effects and cheapness for the treatment of liver diseases. The present study was conducted to examine therapeutic effects of hydroalcoholic extract of <i>Scrophularia striata</i> (<i>S. striata</i>) on thioacetamide-induced liver cirrhosis in rats through evaluate its effects on oxidative stress markers and the expression of metalloproteinase 1 (TIMP 1), toll-like receptor-4 (TLR-4), and Mitofusin (MFN2) genes.</p><p><strong>Methods: </strong>24 male rats were selected by simple random sampling. Rats were randomly assigned to four groups: group I: healthy rats, group II: thioacetamide (TAA) injected rats, group III: TAA injected rats+100 mg/kg bw of <i>S. striata</i> and group IV: TAA injected rats+200 mg/kg bw of <i>S. striata</i>. Liver cirrhosis was induced in rats by a 300 mg/kg bw TAA administration twice with an interval of 24 h. After 8 weeks of treatment by <i>S. striata</i> at doses of 100 and 200 mg/kg bw, biochemical factors and oxidative stress markers (SOD, TAC, GPX, CAT and MDA) were measured using spectrophotometric methods. Also, gene expression of TIMP 1, TLR-4, and MFN2 were analyzed using real-time PCR. ANOVA and Bonferroni post hoc test analysis were applied to evaluate the data.</p><p><strong>Results: </strong>The results showed the <i>S. striata</i> extract significantly improve the serum ALT, AST and ALP levels, TIMP 1, TLR-4, and MFN2 genes and oxidative stress markers (SOD, TAC, GPX, CAT and MDA) in the liver tissues when compared to control group (p<0.05). Also, it was found that the beneficial effects of the <i>S. striata</i> were dose-dependent.</p><p><strong>Conclusions: </strong>Based on the results obtained <i>S. striata</i> by reducing the expression of TIMP 1, TLR-4, and MFN2 genes and improving oxidative stress might be used as adjuvant treatment for liver cirrhosis.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138829494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unexplained subfertility: active or conservative management? 不明原因的不孕症:积极治疗还是保守治疗?
IF 1 Q3 Medicine Pub Date : 2023-12-22 eCollection Date: 2023-12-01 DOI: 10.1515/hmbci-2022-0087
Siti Maisarah Ahmad, Norazilah Mat Jin, Mohd Faizal Ahmad, Abdul Kadir Abdul Karim, Muhammad Azrai Abu

Objectives: Unexplained subfertility (UEI) describes a couple whose standard subfertility workout consider acceptable but unable to conceived.

Methods: This retrospective study was conducted in the Advanced Reproductive Centre, UKM Hospital, Kuala Lumpur, from January 2016 to December 2019. The data of 268 UEI couples were obtained from the clinical database. Women aged 21-45 years old was included and further divided into four groups according to the female partner's age and subfertility duration: group A (age <35 years and subfertility <2 years), group B (age <35 years and subfertility >2 years), group C (age >35 years and subfertility <2 years), and group D (age >35 years and subfertility <2 years). All statistical analyses were performed using SPSS 22.0 for Windows.

Results: A total of 255 cases were included in this study. The mean age of the women was 32.9 ± 4.04 years, and the mean subfertility duration was 5.04 ± 2.9 years. A total of 51 (20 %) cases underwent timed sexual intercourse, 147 (57.6 %) cases had intrauterine insemination (IUI), whereas 57 (22.4 %) cases opted for in vitro fertilization (IVF). A total of 204 cases underwent active management (IUI/IVF), which showed a significant difference (p<0.05). Out of eight clinical pregnancies, half of them were from group B.

Conclusions: Active management in younger women with a shorter subfertility duration revealed a better pregnancy outcome. Otherwise, individualized treatment should be considered in selecting a suitable treatment plan.

目标:不明原因的不孕症(UEI)是指一对夫妇在标准的不孕症治疗过程中认为可以接受,但却无法受孕:这项回顾性研究于2016年1月至2019年12月在吉隆坡UKM医院高级生殖中心进行。从临床数据库中获取了268对UEI夫妇的数据。21-45岁的女性被纳入其中,并根据女性伴侣的年龄和亚不孕持续时间进一步分为四组:A组(年龄2岁)、C组(年龄>35岁且亚不孕35岁且亚不孕 结果:本研究共纳入 255 个病例。妇女的平均年龄为(32.9 ± 4.04)岁,平均亚不孕时间为(5.04 ± 2.9)年。共有 51 人(20%)进行了定时性交,147 人(57.6%)进行了宫腔内人工授精(IUI),而 57 人(22.4%)选择了体外受精(IVF)。共有 204 个病例接受了积极治疗(人工授精/体外受精),两者之间存在显著差异(p 结论:对不孕症持续时间较短的年轻女性进行积极治疗,可获得更好的妊娠结果。否则,在选择合适的治疗方案时应考虑个体化治疗。
{"title":"Unexplained subfertility: active or conservative management?","authors":"Siti Maisarah Ahmad, Norazilah Mat Jin, Mohd Faizal Ahmad, Abdul Kadir Abdul Karim, Muhammad Azrai Abu","doi":"10.1515/hmbci-2022-0087","DOIUrl":"10.1515/hmbci-2022-0087","url":null,"abstract":"<p><strong>Objectives: </strong>Unexplained subfertility (UEI) describes a couple whose standard subfertility workout consider acceptable but unable to conceived.</p><p><strong>Methods: </strong>This retrospective study was conducted in the Advanced Reproductive Centre, UKM Hospital, Kuala Lumpur, from January 2016 to December 2019. The data of 268 UEI couples were obtained from the clinical database. Women aged 21-45 years old was included and further divided into four groups according to the female partner's age and subfertility duration: group A (age <35 years and subfertility <2 years), group B (age <35 years and subfertility >2 years), group C (age >35 years and subfertility <2 years), and group D (age >35 years and subfertility <2 years). All statistical analyses were performed using SPSS 22.0 for Windows.</p><p><strong>Results: </strong>A total of 255 cases were included in this study. The mean age of the women was 32.9 ± 4.04 years, and the mean subfertility duration was 5.04 ± 2.9 years. A total of 51 (20 %) cases underwent timed sexual intercourse, 147 (57.6 %) cases had intrauterine insemination (IUI), whereas 57 (22.4 %) cases opted for <i>in vitro</i> fertilization (IVF). A total of 204 cases underwent active management (IUI/IVF), which showed a significant difference (p<0.05). Out of eight clinical pregnancies, half of them were from group B.</p><p><strong>Conclusions: </strong>Active management in younger women with a shorter subfertility duration revealed a better pregnancy outcome. Otherwise, individualized treatment should be considered in selecting a suitable treatment plan.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138829495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hormone Molecular Biology and Clinical Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1